{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T15:48:17Z","timestamp":1744818497984,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006390","name":"University of Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In this review focus article, we highlight the main modifications introduced in the latest 2022 International Consensus Classification and World Health Organization classification (ICC and WHO-HAEM5) of mature\u00a0T (and NK) cell neoplasms (PTCLs) and consequent implications for diagnostic practice. The changes result from recent advances in the genomic and molecular characterization of PTCLs and enhanced understanding of their pathobiology. Specifically, consideration is given to the following groups of diseases: Epstein\u2013Barr virus (EBV)-associated neoplasms; follicular helper T\u00a0cell lymphoma; anaplastic large cell lymphomas; primary intestinal\u00a0T and NK cell lymphomas and lymphoproliferative disorders; and PTCL, not otherwise specified.<\/jats:p>","DOI":"10.1007\/s00292-023-01260-y","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T14:02:10Z","timestamp":1701698530000},"page":"128-135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["What is new in the classification of peripheral T\u00a0cell lymphomas?","Was gibt es Neues bei der Klassifikation der peripheren T-Zell-Lymphomen?"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3994-516X","authenticated-orcid":false,"given":"Laurence","family":"de Leval","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6840-375X","authenticated-orcid":false,"given":"Bettina","family":"Bisig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,4]]},"reference":[{"key":"1260_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio\u00a0R, Amador\u00a0C, Anagnostopoulos\u00a0I et\u00a0al (2022) The 5th\u00a0edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36:1720\u20131748","journal-title":"Leukemia"},{"key":"1260_CR2","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1200\/JCO.21.02707","volume":"40","author":"C Amador","year":"2022","unstructured":"Amador\u00a0C, Bouska\u00a0A, Wright\u00a0G et al (2022) Gene expression signatures for the accurate diagnosis of peripheral T\u2011cell Lymphoma entities in the routine clinical practice. J\u00a0Clin Oncol 40:4261\u20134275","journal-title":"J Clin Oncol"},{"key":"1260_CR3","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1182\/blood.2019000779","volume":"134","author":"C Amador","year":"2019","unstructured":"Amador\u00a0C, Greiner\u00a0TC, Heavican\u00a0TB et al (2019) Reproducing the molecular subclassification of peripheral T\u2011cell lymphoma-NOS by immunohistochemistry. Blood 134:2159\u20132170","journal-title":"Blood"},{"key":"1260_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1200\/JCO.21.01815","volume":"40","author":"E Bachy","year":"2022","unstructured":"Bachy\u00a0E, Camus\u00a0V, Thieblemont\u00a0C et al (2022) Romidepsin plus CHOP versus CHOP in patients with previously untreated peripheral T\u2011cell Lymphoma: results of the Ro-CHOP phase\u00a0III study (conducted by LYSA). J\u00a0Clin Oncol 40:242\u2013251","journal-title":"J Clin Oncol"},{"key":"1260_CR5","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo\u00a0E, Jaffe\u00a0ES, Cook\u00a0JR et\u00a0al (2022) The international consensus classification of mature lymphoid neoplasms: a\u00a0report from the clinical advisory committee. Blood 140:1229\u20131253","journal-title":"Blood"},{"key":"1260_CR6","doi-asserted-by":"crossref","unstructured":"Cording S, Lhermitte L, Malamut G et al (2022) Oncogenetic landscape of lymphomagenesis in coeliac disease. Gut 71:497\u2013508","DOI":"10.1136\/gutjnl-2020-322935"},{"key":"1260_CR7","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1182\/blood.2020008964","volume":"136","author":"L de Leval","year":"2020","unstructured":"de Leval\u00a0L (2020) Chromosomes in breast lymphoma. Blood 136:2848\u20132849","journal-title":"Blood"},{"key":"1260_CR8","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1182\/blood.2022015854","volume":"140","author":"L de Leval","year":"2022","unstructured":"de Leval\u00a0L, Alizadeh\u00a0AA, Bergsagel\u00a0PL et\u00a0al (2022) Genomic profiling for clinical decision making in lymphoid neoplasms. Blood 140:2193\u20132227","journal-title":"Blood"},{"key":"1260_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00428-022-03434-0","volume":"482","author":"L de Leval","year":"2023","unstructured":"de Leval\u00a0L, Feldman\u00a0AL, Pileri\u00a0S et al (2023) Extranodal T\u2011 and NK-cell lymphomas. Virchows Arch 482:245\u2013264","journal-title":"Virchows Arch"},{"key":"1260_CR10","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","volume":"102","author":"MP Dobay","year":"2017","unstructured":"Dobay\u00a0MP, Lemonnier\u00a0F, Missiaglia\u00a0E et al (2017) Integrative clinicopathological and molecular analyses of angioimmunoblastic T\u2011cell lymphoma and other nodal lymphomas of follicular helper T\u2011cell origin. Haematologica 102:e148\u2013e151","journal-title":"Haematologica"},{"key":"1260_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00428-022-03412-6","volume":"482","author":"AL Feldman","year":"2023","unstructured":"Feldman\u00a0AL, Laurent\u00a0C, Narbaitz\u00a0M et al (2023) Classification and diagnostic evaluation of nodal T\u2011 and NK-cell lymphomas. Virchows Arch 482:265\u2013279","journal-title":"Virchows Arch"},{"key":"1260_CR12","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","volume":"133","author":"TB Heavican","year":"2019","unstructured":"Heavican\u00a0TB, Bouska\u00a0A, Yu\u00a0J et al (2019) Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T\u2011cell lymphoma. Blood 133:1664\u20131676","journal-title":"Blood"},{"key":"1260_CR13","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","volume":"123","author":"J Iqbal","year":"2014","unstructured":"Iqbal\u00a0J, Wright\u00a0G, Wang\u00a0C et al (2014) Gene expression signatures delineate biological and prognostic subgroups in peripheral T\u2011cell lymphoma. Blood 123:2915\u20132923","journal-title":"Blood"},{"key":"1260_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3960\/jslrt.20001","volume":"60","author":"S Kato","year":"2020","unstructured":"Kato\u00a0S, Yamashita\u00a0D, Nakamura\u00a0S (2020) Nodal EBV+ cytotoxic T\u2011cell lymphoma: a\u00a0literature review based on the 2017 WHO classification. J\u00a0Clin Exp Hematop 60:30\u201336","journal-title":"J Clin Exp Hematop"},{"key":"1260_CR15","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/annonc\/mdv575","volume":"27","author":"C Laurent","year":"2016","unstructured":"Laurent\u00a0C, Delas\u00a0A, Gaulard\u00a0P et al (2016) Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes. Ann Oncol 27:306\u2013314","journal-title":"Ann Oncol"},{"key":"1260_CR16","first-page":"360","volume":"135","author":"C Laurent","year":"2020","unstructured":"Laurent\u00a0C, Nicolae\u00a0A, Laurent\u00a0C et al (2020) Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL. Blood 135:360\u2013370","journal-title":"Blood"},{"key":"1260_CR17","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1182\/blood-2018-03-838524","volume":"132","author":"RA Luchtel","year":"2018","unstructured":"Luchtel\u00a0RA, Dasari\u00a0S, Oishi\u00a0N et\u00a0al (2018) Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements. Blood 132:1386\u20131398","journal-title":"Blood"},{"key":"1260_CR18","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1182\/blood.2019000626","volume":"133","author":"RA Luchtel","year":"2019","unstructured":"Luchtel\u00a0RA, Zimmermann\u00a0MT, Hu\u00a0G et al (2019) Recurrent MSC (E116K) mutations in ALK-negative anaplastic large cell lymphoma. Blood 133:2776\u20132789","journal-title":"Blood"},{"key":"1260_CR19","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/s41379-022-01022-w","volume":"35","author":"A Nicolae","year":"2022","unstructured":"Nicolae\u00a0A, Bouilly\u00a0J, Lara\u00a0D et al (2022) Nodal cytotoxic peripheral T\u2011cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations. Mod Pathol 35:1126\u20131136","journal-title":"Mod Pathol"},{"key":"1260_CR20","doi-asserted-by":"crossref","unstructured":"Ondrejka SL, Amador C, Climent F et al (2023) Follicular helper T\u2011cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics\u2014a report of the 2022 EA4HP\/SH lymphoma workshop. Virchows Arch 483:349\u2013365","DOI":"10.1007\/s00428-023-03607-5"},{"key":"1260_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00428-022-03414-4","volume":"482","author":"L Quintanilla-Martinez","year":"2023","unstructured":"Quintanilla-Martinez\u00a0L, Swerdlow\u00a0SH, Tousseyn\u00a0T et al (2023) New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders. Virchows Arch 482:227\u2013244","journal-title":"Virchows Arch"},{"key":"1260_CR22","doi-asserted-by":"publisher","first-page":"12602","DOI":"10.1038\/ncomms12602","volume":"7","author":"A Roberti","year":"2016","unstructured":"Roberti\u00a0A, Dobay\u00a0MP, Bisig\u00a0B et al (2016) Type\u00a0II enteropathy-associated T\u2011cell lymphoma features a\u00a0unique genomic profile with highly recurrent SETD2 alterations. Nat Commun 7:12602","journal-title":"Nat Commun"},{"key":"1260_CR23","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3324\/haematol.2022.282025","volume":"108","author":"KJ Savage","year":"2023","unstructured":"Savage\u00a0KJ, Slack\u00a0GW (2023) DUSP22-rearranged ALK-negative anaplastic large cell lymphoma is a\u00a0pathogenetically distinct disease but can have variable clinical outcome. Haematologica 108:1463\u20131467","journal-title":"Haematologica"},{"key":"1260_CR24","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3324\/haematol.2022.281442","volume":"108","author":"D Sibon","year":"2023","unstructured":"Sibon\u00a0D, Bisig\u00a0B, Bonnet\u00a0C et al (2023) ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a\u00a0LYSA study. Haematologica 108:1590\u20131603","journal-title":"Haematologica"},{"key":"1260_CR25","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3324\/haematol.2019.230961","volume":"105","author":"CR Soderquist","year":"2020","unstructured":"Soderquist\u00a0CR, Patel\u00a0N, Murty\u00a0VV et al (2020) Genetic and phenotypic characterization of indolent T\u2011cell lymphoproliferative disorders of the gastrointestinal tract. Haematologica 105:1895\u20131906","journal-title":"Haematologica"},{"key":"1260_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3324\/haematol.2022.281226","volume":"108","author":"L Veloza","year":"2023","unstructured":"Veloza\u00a0L, Cavalieri\u00a0D, Missiaglia\u00a0E et al (2023) Monomorphic epitheliotropic intestinal T\u2011cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome. Haematologica 108:181\u2013195","journal-title":"Haematologica"},{"key":"1260_CR27","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.3324\/haematol.2021.280003","volume":"107","author":"CMM Wai","year":"2022","unstructured":"Wai\u00a0CMM, Chen\u00a0S, Phyu\u00a0T et al (2022) Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T\/NK-cell lymphoma from ENKTL and PTCL-NOS. Haematologica 107:1864\u20131879","journal-title":"Haematologica"},{"key":"1260_CR28","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1182\/blood.2019001443","volume":"134","author":"W Xiao","year":"2019","unstructured":"Xiao\u00a0W, Gupta\u00a0GK, Yao\u00a0J et al (2019) Recurrent somatic JAK3 mutations in NK-cell enteropathy. Blood 134:986\u2013991","journal-title":"Blood"}],"container-title":["Die Pathologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-023-01260-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-023-01260-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-023-01260-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T08:05:09Z","timestamp":1703145909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-023-01260-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":28,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1260"],"URL":"https:\/\/doi.org\/10.1007\/s00292-023-01260-y","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"type":"print","value":"2731-7188"},{"type":"electronic","value":"2731-7196"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"19 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"L.\u00a0de Leval and B.\u00a0Bisig declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The supplement containing this article is not sponsored by industry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}